cannabis indica

Índice completo — página 74 de 77

Estudos 7.301 a 7.400 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2001 a 1997. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 7.301 a 7.400

  1. 2001

    CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells

    InconclusivoEstudo em AnimaisCâncerCâncer — NeuroblastomaCanabinoides Sintéticos HU-x
  2. 2001

    Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease.

    FavorávelEstudo em AnimaisDoença de HuntingtonAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  3. 2001

    Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Opioides
  4. 2001

    Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth

    FavorávelEstudo em AnimaisCâncerCâncer — TireoideAnandamida (AEA)
  5. 2001

    Delta9-tetrahydrocannabinol Releases And Facilitates The Effects Of Endogenous Enkephalins: Reduction In Morphine Withdrawal Syndrome Without Change In Rewarding Effect

    FavorávelEstudo em AnimaisDependência QuímicaDependência — OpioidesTetraidrocanabinol (THC)
  6. 2001

    Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study

    DesfavorávelEnsaio ClínicoTetraidrocanabinol (THC)THC Farmacêutico+1
  7. 2001

    Early invasive pulmonary aspergillosis in a leukemia patient linked to aspergillus contaminated marijuana smoking

    DesfavorávelMetanáliseInfecções Fúngicas
  8. 2001

    Endogenous Cannabinoid, 2-arachidonoylglycerol, Attenuates Naloxone-precipitated Withdrawal Signs In Morphine-dependent Mice

    FavorávelEstudo em AnimaisDependência QuímicaDependência — OpioidesTetraidrocanabinol (THC)2-Araquidonoilglicerol (2-AG)+1
  9. 2001

    Examination of the immunosuppressive effect of delta9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes.

    FavorávelEstudo em AnimaisDiabetesTetraidrocanabinol (THC)
  10. 2001

    Geraniol, a Component of Plant Essential Oils, Inhibits Growth and Polyamine Biosynthesis in Human Colon Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Cólon
  11. 2001

    Hemp for headache: An in-depth historical and scientific review of cannabis in migraine treatment.

    FavorávelMetanáliseEnxaquecaAnandamida (AEA)Tetraidrocanabinol (THC)+2
  12. 2001

    Hu 210: a potent tool for investigations of the cannabinoid system

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaCanabinoides Sintéticos HU-x+4
  13. 2001

    Influence Of Treatment Of Tourette Syndrome With Delta9-tetrahydrocannabinol (delta9-THC) On Neuropsychological Performance

    FavorávelEnsaio Clínico Duplo-CegoTiques e Síndrome de TouretteTetraidrocanabinol (THC)
  14. 2001

    Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor

    FavorávelEstudo em AnimaisCâncerCâncer — CérebroCanabinoides Sintéticos SR-xCanabinoides Sintéticos JWH-x
  15. 2001

    Marijuana abstinence effects in marijuana smokers maintained in their home environment

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisTetraidrocanabinol (THC)
  16. 2001

    Marijuana for the Management of Proximal Myotonic Myopathy

    FavorávelMetanáliseDistrofia Muscular e Distúrbios Miotônicos
  17. 2001

    Marijuana In The Management Of Amyotrophic Lateral Sclerosis

    FavorávelMetanáliseEsclerose Lateral Amiotrófica (ELA)
  18. 2001

    Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasExcitotoxicidadeTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  19. 2001

    Opioid And Cannabinoid Modulation Of Precipitated Withdrawal In Delta(9)-tetrahydrocannabinol And Morphine-dependent Mice

    FavorávelEstudo em AnimaisDependência QuímicaDependência — OpioidesTetraidrocanabinol (THC)
  20. 2001

    Progesterone receptor and dopamine receptors are required in Δ9-tetrahydrocannabinol modulation of sexual receptivity in female rats

    FavorávelEstudo em AnimaisLibidoDisfunção ErétilTetraidrocanabinol (THC)
  21. 2001

    Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.

    FavorávelEstudo em AnimaisDependência QuímicaDependência — OpioidesTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  22. 2001

    Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock

    InconclusivoMetanáliseSepseSíndrome do Choque TóxicoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  23. 2001

    Tetrahydrocannabinol for treatment of chronic pain

    InconclusivoMetanálise ClínicaDorDor — CrônicaTetraidrocanabinol (THC)
  24. 2001

    The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study

    InconclusivoEstudo em AnimaisExcitotoxicidadeCanabinoides Sintéticos WIN-x
  25. 2001

    The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies

    FavorávelEnsaio ClínicoGlaucomaCanabinoides Sintéticos WIN-x
  26. 2001

    Treating the substance-abusing suicidal patient

    DesfavorávelMetanálise ClínicaTentativa de Suicídio
  27. 2001

    Treatment of Tourette-Syndrome with ∆9-Tetrahydrocannabinol (THC): a randomized crossover trial

    FavorávelEnsaio Clínico Duplo-CegoTiques e Síndrome de Tourette
  28. 2001

    Vanilloid receptor ligands: hopes and realities for the future

    FavorávelMetanáliseHerpes-Zóster
  29. 2000

    Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaCanabinoides Sintéticos SR-xCanabinoides Sintéticos HU-x+2
  30. 2000

    Anandamide Induces Apoptosis In Human Cells Via Vanilloid Receptors: Evidence For A Protective Role Of Cannabinoid Receptors

    FavorávelEstudo LaboratorialCâncerCâncer — LinfomaSarcoma de KaposiAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+1
  31. 2000

    Atrial Fibrillation Associated With Marijuana Use

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Fibrilação Atrial
  32. 2000

    Cannabinoids Control Spasticity And Tremor In A Multiple Sclerosis Model.

    FavorávelEstudo em AnimaisEsclerose MúltiplaCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x+2
  33. 2000

    Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

    FavorávelEstudo em AnimaisDorDor — AgudaAnandamida (AEA)Canabinoides Sintéticos CP-x
  34. 2000

    Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats

    FavorávelEstudo em AnimaisObesidadeSíndrome MetabólicaCanabinoides Sintéticos HU-x
  35. 2000

    Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

    FavorávelEstudo em AnimaisDoença de ParkinsonAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  36. 2000

    In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes.

    FavorávelEstudo LaboratorialDisfunção CognitivaEsclerose MúltiplaDoença de Alzheimer+1
  37. 2000

    Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding

    FavorávelEstudo LaboratorialCanabinoides Sintéticos JWH-x
  38. 2000

    Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour

    DesfavorávelEstudo em AnimaisIntoxicação por Cannabis SintéticaLibidoDisfunção ErétilCanabinoides Sintéticos HU-x
  39. 2000

    Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2.

    FavorávelEstudo em AnimaisGlaucomaCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x
  40. 2000

    Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction.

    FavorávelEstudo em AnimaisDependência QuímicaDoença de AlzheimerDependência — Nicotina
  41. 2000

    Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome.

    FavorávelEstudo em AnimaisDependência QuímicaDependência — OpioidesCanabinoides Sintéticos SR-x
  42. 2000

    N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.

    FavorávelEstudo em AnimaisN-Araquidonoil Dopamina (NADA)
  43. 2000

    Paroxysmal Atrial Fibrillation in a Young Female Patient Following Marijuana Intoxication--A Case Report of Possible Association

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Fibrilação Atrial
  44. 2000

    Phase I pharmacokinetic trial of perillyl alcohol in patients with refractory solid malignancies

    InconclusivoEnsaio ClínicoCâncerCâncer — MamaCâncer — Próstata
  45. 2000

    Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences

    DesfavorávelEstudo em AnimaisGestaçãoAlterações Cerebrais NeonataisTetraidrocanabinol (THC)
  46. 2000

    Risperidone compared to haloperidol in cannabis-induced psychotic disorder: A double blind randomized controlled trial

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisPsicose
  47. 2000

    Standardized stimuli to assess drug craving and drug memory in addicts

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+2
  48. 2000

    Suppression Of Nerve Growth Factor Trk Receptors And Prolactin Receptors By Endocannabinoids Leads To Inhibition Of Human Breast And Prostate Cancer Cell Proliferation

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCâncer — PróstataAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  49. 2000

    The importance of the endogenous cannabinoid system in various neuropsychiatric disorders

    FavorávelMetanáliseDependência — OpioidesAVCTiques e Síndrome de TouretteAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  50. 2000

    The Nonpsychoactive Cannabis Constituent Cannabidiol Is An Oral Anti-arthritic Therapeutic In Murine Collagen-induced Arthritis

    FavorávelEstudo em AnimaisInflamaçãoArtrite
  51. 2000

    The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.

    FavorávelEstudo LaboratorialDoença de Huntington
  52. 1999

    [Cannabis and pregnancy]

    FavorávelEnsaio ClínicoGestação
  53. 1999

    3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

    FavorávelEstudo LaboratorialCanabinoides Sintéticos JWH-x
  54. 1999

    A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial

    InconclusivoEnsaio ClínicoPsicose
  55. 1999

    A validity study of the SSAGA--a comparison with the SCAN

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Álcool+3
  56. 1999

    Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol.) Warb. by Waiãpi Amazon Indians.

    FavorávelEstudo LaboratorialMalária
  57. 1999

    Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol

    InconclusivoEstudo em AnimaisGestaçãoAlterações Cerebrais NeonataisTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  58. 1999

    Cannabinoids as antioxidants and neuroprotectants.

    FavorávelMetanáliseDorDisfunção CognitivaDoenças NeurodegenerativasTetraidrocanabinol (THC)Canabinoide Sintético (não especificado)+6
  59. 1999

    Cannabis In Movement Disorders

    FavorávelMetanáliseDoença de ParkinsonDoença de HuntingtonTiques e Síndrome de Tourette+1
  60. 1999

    Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study

    InconclusivoEnsaio ClínicoGastroparesiaDelta-8-THC
  61. 1999

    Differential Cholera-Toxin Sensitivity of Supraspinal Antinociception Induced by the Cannabinoid Agonists delta9-THC, WIN 55,212-2 and Anandamide in Mice

    InconclusivoEstudo em AnimaisCóleraAnandamida (AEA)Canabinoides Sintéticos WIN-x
  62. 1999

    Effect of cannabis use on cognitive functions and driving ability

    DesfavorávelEnsaio ClínicoDisfunção Cognitiva
  63. 1999

    Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisIntoxicação por Cannabis SintéticaCanabinoides Sintéticos HU-x
  64. 1999

    Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck

    DesfavorávelMetanáliseCâncerCâncer — Escamoso de Cabeça e Pescoço
  65. 1999

    Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats

    InconclusivoEstudo em AnimaisGestaçãoAlterações Cerebrais NeonataisTetraidrocanabinol (THC)
  66. 1999

    Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana.

    FavorávelMetanáliseDependência — Cannabis
  67. 1999

    Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease

    FavorávelEnsaio Clínico Duplo-CegoDoença de Parkinson
  68. 1999

    Therapeutic use of cannabis by crack addicts in Brazil

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cocaína
  69. 1999

    Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

    FavorávelEstudo em AnimaisDorDependência QuímicaDoenças Cardiovasculares (DCV)+3
  70. 1999

    Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis.

    FavorávelEstudo LaboratorialOnicomicose
  71. 1999

    Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Hipertensão ArterialAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  72. 1999

    Δ9-Tetrahydrocannabinol Induces Apoptosis In Human Prostate PC-3 Cells Via A Receptor-independent Mechanism

    FavorávelEstudo LaboratorialCâncerCâncer — PróstataTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x+1
  73. 1998

    Anandamida modulates sleep and memory in rats.

    FavorávelEstudo em AnimaisInsônia e Distúrbios do SonoAnandamida (AEA)Outros Compostos Relacionados
  74. 1998

    Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells

    FavorávelEstudo LaboratorialCâncerCâncer — BocaCanabigerol (CBG)
  75. 1998

    Cannabidiol and Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças NeurodegenerativasTetraidrocanabinol (THC)
  76. 1998

    Cannabidiol and Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

    FavorávelEstudo LaboratorialDoenças NeurodegenerativasAVCTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x+1
  77. 1998

    Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla

    FavorávelEstudo em AnimaisDorDor — CrônicaDor — AgudaCanabinoides Sintéticos HU-x
  78. 1998

    Cannabis for migraine treatment: the once and future prescription? An historical and scientific review

    FavorávelMetanáliseEnxaqueca
  79. 1998

    Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats

    FavorávelEstudo LaboratorialDisfunção CognitivaCondições GeriátricasLongevidade
  80. 1998

    Immunology in medical practice. XIV. Central nervous system complications in systemic autoimmune diseases

    InconclusivoMetanáliseArtriteArtrite — ReumatoideLúpus
  81. 1998

    Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro.

    FavorávelEstudo LaboratorialCOVID-19AsmaTosse
  82. 1998

    Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana

    InconclusivoEnsaio ClínicoDisfunção Cognitiva
  83. 1998

    Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats

    FavorávelEstudo LaboratorialCondições GeriátricasLongevidadeCanabinoide Sintético (não especificado)
  84. 1998

    Marijuana for intractable hiccups.

    FavorávelMetanáliseHIV/AIDSSoluços
  85. 1998

    Marijuana Smoking vs Cannabinoids for Glaucoma Therapy.

    FavorávelMetanáliseGlaucoma
  86. 1998

    Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats

    DesfavorávelEstudo em AnimaisDependência — OpioidesGestaçãoTetraidrocanabinol (THC)
  87. 1998

    Modulation of delta9-tetrahydrocannabinol-induced Hypothermia by Fluoxetine in the Rat

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — FIRES
  88. 1998

    Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats

    InconclusivoEstudo em AnimaisGestaçãoTetraidrocanabinol (THC)
  89. 1998

    Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats

    DesfavorávelEstudo em AnimaisDependência — OpioidesGestaçãoTetraidrocanabinol (THC)
  90. 1998

    Phase I and Pharmacokinetic Study of D-limonene in Patients With Advanced Cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee

    FavorávelEnsaio ClínicoCâncerCâncer — Mama
  91. 1998

    Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells

    InconclusivoEstudo LaboratorialCâncerCâncer — NeuroblastomaTetraidrocanabinol (THC)
  92. 1998

    SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor

    FavorávelEstudo em AnimaisCanabinoides Sintéticos SR-x
  93. 1998

    The Endogenous Cannabinoid Anandamide Inhibits Human Breast Cancer Cell Proliferation

    FavorávelEstudo LaboratorialCâncerCâncer — MamaAnandamida (AEA)Canabinoides Sintéticos HU-x
  94. 1998

    The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway.

    FavorávelEstudo em AnimaisEsclerose MúltiplaEncefalite e MieliteAnandamida (AEA)Outros Compostos Relacionados
  95. 1998

    The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research.

    FavorávelMetanáliseTranstorno Bipolar
  96. 1998

    Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells

    FavorávelEstudo LaboratorialCâncerCâncer — CérebroCanabinoides Sintéticos SR-x
  97. 1997

    Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

    FavorávelEstudo em AnimaisChoque HemorrágicoCanabinoides Sintéticos SR-x
  98. 1997

    Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.

    InconclusivoEstudo LaboratorialCâncerCâncer — Neuroblastoma
  99. 1997

    Composition and antimalarial activity in vitro of the essential oil of Tetradenia riparia.

    FavorávelEstudo LaboratorialMalária
  100. 1997

    Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

    FavorávelEstudo em AnimaisTraumatismo CranioencefálicoCanabinoides Sintéticos HU-x